INDIA GLYCOLS LTD.

India Glycols Ltd has issued a reminder to its security holders with shares in physical form regarding the mandatory submission of Permanent Account Number (PAN), Know Your Client (KYC) details, and choice of nomination. This action is in line with SEBI circulars mandating these updates for physical security holders. Failure to comply will restrict grievance lodging, service requests, and electronic payment of dividends or interest starting April 1, 2024. The company has provided specific forms (ISR-1, ISR-2, SH-13, SH-14, ISR-3) and contact details for the Registrar & Share Transfer Agent, MCS Share Transfer Agent Limited, and the company's Company Secretary for assistance. Shareholders are also encouraged to dematerialize their shares.

India Glycols Ltd announced that the Board of Directors, in a meeting held on August 12, 2026, approved the re-designation of Ms. Pragya Bhartia Barwale from Whole Time Director and Key Managerial Person to Non-Executive Non-Independent Director. This change is effective from the closure of business hours on August 12, 2026. The company affirmed that Ms. Barwale is not debarred from holding a director's office. The filing also disclosed her relationship with other directors, including the Chairman & Managing Director.

India Glycols Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, has approved the Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2026. The results were reviewed by the Audit Committee and have been subject to a limited review by the Statutory Auditors. The filing also provides segment-wise financial data and details the progress of a Scheme of Arrangement involving demerger, which has received sanction from the NCLT.

India Glycols' consolidated Q1 FY27 (quarter ended June 30, 2026) revenue rose 19.39% YoY to ₹2,988.44 Cr and PAT rose 32.18% YoY to ₹96.83 Cr (basic EPS ₹14.45 vs ₹11.83), with NPM expanding to 3.24% from 2.92% a year ago. Sequentially revenue was up 26.63% QoQ and PAT up 11.45% QoQ, but profit growth trailed revenue growth QoQ as NPM slipped from 3.68% in Q4 FY26 — consistent with summer being the seasonally strongest quarter for the Potable Spirits business rather than a step-change in profitability. No analyst consensus or preview for this print turned up in a web search ahead of the company's scheduled August 14, 2026 earnings call, so vsStreet is unknown. The headline PAT growth is driven less by core operations than by two below-the-line items: finance costs fell 43.6% YoY to ₹25.18 Cr from ₹44.68 Cr, saving roughly ₹19.5 Cr and directly reflecting management's stated debt-reduction priority from the Q4 FY26 call; and the JV profit share (Clariant IGL Specialty Chemicals) rose to ₹20.60 Cr from ₹18.62 Cr. Combined segment EBIT grew only 9.2% YoY to ₹140.70 Cr — slower than the 19.4% revenue growth — and consolidated EBITDA margin actually compressed to 5.69% from 6.03% a year ago (7.08% in Q4 FY26). Potable Spirits (74% of revenue, +22.9% YoY) saw its EBIT margin fall to 3.38% from 4.01%, at odds with management's guidance that premiumization would lift margins there; Bio-based Specialities & Performance Chemicals grew revenue 21.1% YoY but EBIT fell 3.7% as margin compressed to 8.64% from 10.87%, only partly bearing out the guided 'significant growth' in value-added chemicals. Bio-Fuel bucked the pattern — revenue fell 7.0% YoY to ₹323.22 Cr but segment EBIT still rose 19.2% to ₹27.03 Cr, a profitability improvement even as volumes softened. Against Q4 FY26 guidance, the debt-reduction/lower-interest-cost commitment is clearly on track and revenue growth in Potable Spirits and Performance Chemicals came through as flagged, but the margin-expansion promise in both segments has not yet shown up at the EBIT line — a 'met on revenue and financing, incomplete on margins' read. This quarter's management changes (Pragya Bhartia Barwale moving to Non-Executive Director; senior personnel transferred to subsidiary IGL Spirits; a new Executive Director & COO appointed at a subsidiary) coincide with the NCLT-sanctioned demerger of the Spirits & Biofuel and Bio Pharma undertakings into separately listed IGL Spirits Limited and Ennature Bio Pharma Limited (order dated July 17, 2026, appointed date April 1, 2026), which the company states has no bearing on this quarter's reported numbers. Standalone PAT of ₹76.59 Cr (EPS ₹11.43) grew a faster 44.9% YoY than consolidated's 32.18%, since standalone excludes the JV share — the two bases diverge by over 3 points here, but the consolidated figure is the primary read.

India Glycols Ltd has announced its Earnings Conference Call for the first quarter of the fiscal year 2027 (Q1FY27). The call is scheduled to take place on Friday, August 14th, 2026, at 16:00 Hrs IST. The company will host its senior management, including the Chief Executive Officer, Executive Directors, and Chief Financial Officer, to discuss the financial performance and outlook. The details of the conference call, including dial-in numbers and an option to express join via DiamondPassTM, have been provided. This information is also available on the company's website, www.indiaglycols.com.

India Glycols Ltd has announced that its Board of Directors will convene on August 12, 2026, to consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2026. The results will be both standalone and consolidated. The company also informed that the trading window, which opened on July 1, 2026, will remain closed until August 14, 2026, inclusive. This meeting is scheduled as per SEBI's Listing Obligations and Disclosure Requirements.

India Glycols Ltd has announced a board meeting scheduled for August 12, 2026, to consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2026, both on a standalone and consolidated basis. Concurrently, the company has confirmed that the trading window for its securities, which was closed from July 1, 2026, will remain shut until August 14, 2026. This closure is in accordance with SEBI regulations and the company's internal code of conduct for trading in securities.

India Glycols Ltd (IGL) has announced a material update regarding its wholly-owned subsidiary, IGL Spirits Limited (IGSL). Shri Manoj Kumar Rai has been appointed as an Additional Director (Executive Director) and Key Managerial Personnel, designated as Executive Director & Chief Operating Officer of IGSL, effective August 4, 2026. This appointment is for a term of five years, concluding on August 31, 2031, subject to shareholder approval. Mr. Rai brings over 27 years of experience in business strategy and P&L management across various industries. This disclosure is made in connection with a Scheme of Arrangement involving India Glycols, Ennature Bio Pharma, and IGSL.

India Glycols Ltd has announced the transfer of Shri Akshay Bansal, Head- Sales & Marketing of Ennature Biopharma Division, to its wholly-owned subsidiary, Ennature Bio Pharma Limited (EBL). Consequently, Mr. Bansal ceased to be a Senior Managerial Personnel (SMP) of India Glycols Ltd from July 30, 2026. EBL has appointed Mr. Bansal as Additional Director (Executive Director) and Key Managerial Personnel (KMP) with effect from July 31, 2026, for a term of five years. This change is part of a Scheme of Arrangement involving India Glycols, EBL, and IGL Spirits Limited. Mr. Bansal brings 26 years of experience in pharmaceuticals, nutraceuticals, and nicotine industries.

India Glycols Ltd has announced a change in its Senior Managerial Personnel (SMP). Shri Akshay Bansal, formerly Head- Sales & Marketing of Ennature Biopharma Division, has been transferred to Ennature Bio Pharma Limited (EBL), a wholly-owned subsidiary. Consequently, he ceased to be an SMP of India Glycols Ltd from July 30, 2026. EBL has appointed Shri Bansal as Additional Director (Executive Director) and Key Managerial Personnel (KMP) of EBL, effective July 31, 2026, for a term of five years, subject to shareholder approval. This move is part of a larger Scheme of Arrangement involving India Glycols, EBL, and IGL Spirits Limited.